Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia
NCT01027624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2011-04-15
Summary
This is a multi-centre survey of patients who are currently on lipid lowering pharmacological treatment in South Africa.
Conditions
- Undertreatment of Hypercholesterolaemia
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Prof F Raal · National Co-ordinator
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2010-04-30
- Completion
- 2010-04-30
Countries
- South Africa
Study Locations
More Related Trials
-
An Observational Study Evaluating Cholesterol Levels in Patients on Cholesterol Lowering Drugs in Jordan and Lebanon
NCT01614561 ·Status: COMPLETED
-
Study of Undertreatment of Patients With Dyslipidemia in Bulgaria
NCT01075594 ·Status: COMPLETED
-
Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
NCT02942602 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety, Efficacy and Tolerability of AZD8233 Treatment in Participants With Hyperlipidaemia
NCT04964557 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare the Efficacy and Safety of Pitavastatin and Pravastatin in Elderly Patients
NCT00257686 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C
NCT06165250 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in People With High Cholesterol
NCT00133380 ·Status: COMPLETED ·Phase: PHASE2
-
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder
NCT00134511 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia
NCT05930028 ·Status: COMPLETED ·Phase: PHASE3
-
Functional and Clinical Impact of CYP3A Genetic Polymorphisms on Statin Therapy
NCT01867203 ·Status: WITHDRAWN
-
Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal
NCT00781560 ·Status: COMPLETED
-
CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II)
NCT02230241 ·Status: COMPLETED
-
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
NCT00536796 ·Status: COMPLETED
-
Observational Study to Understand Patients' and Physicians' Attitudes to Statins in TurkeY
NCT01625884 ·Status: COMPLETED
-
Special Drug Use-Results Survey of Lipitor Tablets
NCT01446679 ·Status: COMPLETED
-
EZETROL® Re-examination Study (MK0653-175)(COMPLETED)
NCT01070953 ·Status: COMPLETED
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subjects
NCT05384262 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH
NCT07000136 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006
NCT00695357 ·Status: COMPLETED
-
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
NCT01435382 ·Status: COMPLETED ·Phase: PHASE1
-
Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis
NCT04072601 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia
NCT05206578 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A
NCT05970679 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
NCT00330876 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia
NCT00143676 ·Status: COMPLETED ·Phase: PHASE3